
The chemical Maga fears is making us infertile
'Millions of Americans who want clean air, clean water and a healthy nation have concerns about toxins in our environment and pesticides in our food,' Donald Trump said at a rally in Arizona last August.
On Thursday, Robert F Kennedy Jr, the health secretary, will preview a report into potential causes of chronic illness in children, including lack of exercise, screen time and pesticides.
The report has largely been co-ordinated by Calley Means, a wellness influencer in the Make America Healthy Again (Maha) movement and the brother of Mr Trump's new pick for surgeon general, Dr Casey Means.
Announcing Dr Means's nomination, the president touted her as having 'amazing Maha credentials'.
The physician-turned-wellness influencer and holistic farming advocate is just one of many in Mr Trump's orbit pushing for the phasing out of glyphosate – the world's most common weed killer and the main ingredient in the pesticide Roundup.
Glyphosate has been considered 'probably' a carcinogen by the World Health Organisation since 2015, although the Environmental Protection Agency (EPA) in the US says it is not cancer-casing.
Dr Means, a key ally of Mr Kennedy's, is also concerned about the chemical's link to infertility and sperm reduction.
She wrote in a newsletter last year: 'I want to share how your health (and your family's health) can be transformed by learning about – and reducing – exposure to pesticides.
'Too many people are sick right now, from kids with autism, ADHD and asthma, to middle-aged friends with infertility, gut issues, and anxiety, to older friends with cancer and early dementia.
'Some of the most commonly used pesticides… promote the conversion of testosterone to oestrogen, which can have negative effects in women (like increased breast cancer risk, infertility), men (depletion of testosterone, infertility), and foetuses (birth defects).'
Views on glyphosate backed by science
Posting to Instagram, the Maha influencer wrote last year: 'Chronic diseases and infertility are largely rooted in the same thing: metabolic dysfunction from cells that are broken due to a toxic industrial world…
'The single most effective strategy that I believe can solve the most pressing human health issues… is restoring sustainable agriculture practices that contribute to biodiverse soil and nutrient-rich food, and moving away from industrial agriculture that uses toxic synthetic pesticides.'
Mr Trump, and the wider Maha movement is concerned over an apparent decline in fertility in recent decades.
Mr Trump has even referred to himself as the 'fertilisation president'.
In a post on her blog, Dr Means claims that, since the 1970s 'cumulatively, we're looking at a 50 [to] 60 per cent decline in total fertility rate, testosterone, and sperm counts'.
While several factors can influence these rates, The World Economic Forum estimates there has been a 50 per cent decrease in fertility in the last 70 years.
Other studies cite a significant drop in testosterone and sperm count during the same period.
Although Dr Means's nomination has faced pushback in recent days, with Trump cheerleader Laura Loomer calling her 'a total crackpot' owing to her inactive medical licence, her views on glyphosate appear to be backed by science.
A review published earlier this year in the journal Reproductive Sciences suggested exposure to glyphosate-based herbicides (GBH) could disrupt female hormones, cause uterine and ovary damage, and increase infertility or miscarriage.
The study also connected the conditions of endometriosis and polycystic ovarian syndrome with the chemical.
The team of scientists, from Wayne State University School of Medicine in Detroit, said: 'These GBH-induced alterations in uterine architecture and morphology may contribute to infertility, early pregnancy loss, and endometrial hyperplasia.'
'Negative impact on reproductive health'
Meanwhile, in a separate study of sperm taken from infertile men at Centre de fertilité Pôle Santé Léonard de Vinci in Chambray-lès-Tours, France, last year, more than 55 per cent of samples were found to contain high levels of glyphosate.
A link was also found between the chemical and oxidative stress on seminal plasma, which can impair sperm vitality.
'Taken together, our results suggest a negative impact on glyphosate on human reproductive health and possibly on offspring,' wrote the authors of the study, conducted in partnership with the University De Tours and the University De Limoges, and published in the journal Ecotoxicology and Environmental Safety.
People particularly at risk were those who ate non-organic produce, agricultural workers and smokers, the study concluded.
'Glyphosate impacts male reproductive systems'
Another health influencer campaigning for the phase-out of glyphosate and adoption of regenerative agriculture is Kelly Ryerson, also known to her 62,500 Instagram followers as The Glyphosate Girl.
'Glyphosate impacts male reproductive systems by disrupting hormonal balance, decreasing sperm quality and quantity and causing testicular damage,' claims Ms Ryerson.
'Glyphosate also disrupts key pregnancy hormones, oestrogen and progesterone, and has been linked to damage to ovarian and uterine structures. Studies also connect glyphosate to alterations in blood vessel formation and embryo implantation.
'With the crash in sperm quantity and rising levels of women unable to get pregnant or stay pregnant through term, it is critical that our regulators fast-track the assessment of the impact of glyphosate on fertility,' she told The Telegraph.
And it is not just in the US that concerns over the chemical are growing.
'The effect of glyphosate on humans and animals is indirect,' said Dr Amy Godfrey, a doctor who formerly worked with the NHS.
She said that, because the chemical works by inhibiting an enzyme not present in animals and humans, 'we assumed from a biochemical standpoint that it was safe'.
After years of seeing the downstream health effects of agriculture and the food system, Dr Godfrey changed careers to drive change in the food system.
She is now head of research for The First Thirty, a venture capital firm investing in agriculture and health.
'This perceived safety is one of many gross simplifications we see in the connection between agriculture and human health,' she said, adding that 'the potential impact of glyphosate on our gut microbiome is huge'.
As for its effect on human fertility, Dr Godfrey points to animal studies which suggest glyphosate acts as a disruptor to the body's endocrine system, which is responsible for hormone production.
'Rats and mice exposed to glyphosate show increased rates of embryonic resorption, which is a proxy for early miscarriage, altered progesterone levels, dysfunctional implantation [and] structural changes in the ovaries and uterus,' she told The Telegraph.
More than 180,000 lawsuits
Roundup, which contains glyphosate as an active ingredient was acquired by Bayer, the pharmaceutical company, in 2018.
According to Bayer's website, as of Jan 31 2025, 114,000 out of approximately 181,000 glyphosate-related lawsuits 'have been resolved or deemed to be ineligible'.
In his past career as a lawyer, Mr Kennedy helped to secure a $289 million payout for a groundskeeper who developed cancer after working with a glyphosate-based weed killer.
As concern continues to grow regarding the impact of pesticides on human health, and amid the EPA's failure to restrict or prohibit such chemicals, widely banned by other nations, individual towns and communities are taking matters into their own hands.
Some states, like New York, have banned the use of glyphosate on public property, while other cities and counties such as Los Angeles, Seattle, Miami, Austin and Portland have taken action to restrict or ban the substance.
However, glyphosate is still the most commonly used herbicide used on soybean, corn and cotton.
In the US, about 280 million pounds of glyphosate are applied annually to around 298 million acres of cropland to control broadleaf, sedge, grass and weeds.
Bayer has repeatedly insisted that Roundup is safe and has been tested extensively.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
24 minutes ago
- The Guardian
Alzheimer's blood test can spot people with early symptoms, study suggests
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia by examining two proteins in blood plasma. The proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque buildup, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the journal Alzheimer's and Dementia, said the test was as good as more invasive tests in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who showed no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting,' he added. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline, though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US. We hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multimillion-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the National Health Service by 2029. Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40 and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'


Sky News
4 hours ago
- Sky News
Blood test for Alzheimer's disease is highly accurate, researchers say
Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - and found the test was 95% accurate in identifying patients with existing cognitive impairment linked to the condition. The US study involved 509 patients in an outpatient memory clinic in Florida and was published in the medical journal Alzheimer's and Dementia. The test, which has already been approved by the US regulator, was also 82% accurate for specificity, which means it could rule out people without dementia. Dr Gregg Day, who led the study, said the test was as good as existing, but more invasive, tests. He said the next step was to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms. Scientists say the two proteins, which they have identified in blood plasma, are associated with the buildup of amyloid plaques. Amyloid protein can be found in our brains, but in Alzheimer's disease, amyloid sticks together and forms abnormal deposits, which are thought to be toxic to brain cells. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results "suggest this test is very accurate". "Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before," he added. In the UK, the Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. 1:09 Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal." She said the studies like the Blood Biomarker Challenge are a "crucial part of making diagnosis easier and faster, which will bring us closer to a cure". "The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK," she added.


Daily Mail
5 hours ago
- Daily Mail
A-ha frontman Morten Harket, 65, diagnosed with Parkinson's disease and doesn't know if he can sing anymore as band writes 'he has been battling his own body' in recent years
A-ha frontman Morten Harket has revealed he has Parkinson's disease. Parkinson's is a progressive brain disorder caused by the death of nerve cells in the brain that produce dopamine. In a statement on the band's website, Morten, 65, said he had undergone several rounds of brain surgery and that he was managing the symptoms of the disease, but admitted he had been 'battling his own body' in recent years. It read: 'This isn't the sort of news anyone wants to deliver to the world, but here it is: Morten has Parkinson's disease.' Morten also said he had initially kept the degenerative condition private but has now decided to tell fans and didn't know if he could sing or even perform again. He said: 'I've got no problem accepting the diagnosis. With time I've taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: "I use whatever works" From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the Daily Mail's new showbiz newsletter to stay in the loop. 'Part of me wanted to reveal it. Like I said, acknowledging the diagnosis wasn't a problem for me; it's my need for peace and quiet to work that has been stopping me. 'I'm trying the best I can to prevent my entire system from going into decline. 'It's a difficult balancing act between taking the medication and managing its side effects. 'There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general.' He told the band's biographer Jan Omdahl that he has been making the most of advanced technology in treating the disease and has been using a method called deep brain stimulation. His neurologist in Norway is Dr Christina Sundal at NeuroClinic Norway, and she was previously a research fellow with the Parkinson's team at the Mayo Clinic. He revealed he underwent a neurosurgical procedure called deep brain stimulation (DBS) in June 2024 in which electrodes were implanted into the left side of his brain and he responded well and many of his physical symptoms practically vanished. In December 2024 he underwent a similar procedure on the right side of his brain, which was also successful. His voice has changed with Parkinson's and told Jan: The problems with my voice are one of many grounds for uncertainty about my creative future.' He said: 'I don't really know [if I can sing anymore]. I don't feel like singing, and for me that's a sign. I'm broadminded in terms of what I think works; I don't expect to be able to achieve full technical control. 'The question is whether I can express myself with my voice. As things stand now, that's out of the question. But I don't know whether I'll be able to manage it at some point in the future.' Morten urged fans not to worry, telling them he is now 'going to listen to the professionals'. 'Spend your effort addressing real problems,' he said, 'and know that I am being taken care of. 'Be good servants to nature, the very basis of our existence, and care for the environment while it is still possible to do so. 'Don't worry about me. Find out who you want to be - a process than can be new each and every day.' The singer too revealed that he has been writing lyrics since his diagnosis, but that he's 'not sure' if he'll be able to finish and release them. Parkinson's can affect those diagnosed both physically and mentally. It primarily causes trouble to the brain, parts of which become progressively damaged over years with the disease. It usually affects those over 50, with a number of celebrities ultimately suffering with the disease in the past. Ozzy Osborne, Neil Diamond and Billy Connolly are all currently living with Parkinson's while Muhammad Ali was famously diagnosed just three years after the end of his illustrious boxing career. Doctors said of the heavyweight's illness following his 2016 death: 'Muhammad Ali's disease course, from his late 30s until his death at age 74 years, was chronic and progressive. 'He manifested fatigue hypophonia, bradykinesia, and a masked face, as well as many of the visible motor symptoms of Parkinons's disease.' As evidenced in the Ali case, the disease can in rare cases affect those under the age of 40. Famous US actor Michael J. Fox, 63, was diagnosed at just 29 years old in 1991. The Back To The Future star has spent much of the last 25 years trying to advance scientific research into the disease with his charity, The Michael J. Fox Foundation for Parkinson's Research. Formed in 1982 by Harket and his friends Paul Waaktaar-Savoy and Magne Furuholmen, A-ha saw a global breakthrough in 1985 with their debut album Hunting High and Low which yielded several hits such as Take On Me and The Sun Always Shines on TV. Take On Me was recently featured in the second season of HBO's hit series The Last of Us when the main character Ellie, played by Bella Ramsey, performed an acoustic version of the song. While world-renowned for their success in the 1980s, A-ha continued to release music throughout the 2000s with their latest work including albums such as Memorial Beach, Lifelines and Cast in Steel. Morten has six children, three with his former wife Camilla Malmquist Harket, a daughter with former girlfriend Anne Mette Undlien and another daughter with current partner Inez Andersson.